Medical devices

New technology and a changing focus is driving growth in the medtech sector.

The changing focus in healthcare from treatment to prevention and an increased user-centric approach is propelling medtech progress. The rapid uptake of technology using the capabilities of consumer devices and wearables, the application of big data and human-led innovation is fueling the wave of change.

Digital technology has entered all aspects of the industry, whether it is companies that specialise in AI and machine learning, robotics, telehealth and apps, or more traditional companies who must adapt and adopt such technologies to survive and thrive.

Medtech is a marketplace with unique challenges – global multinationals sit side-by-side with SMEs, universities and clinician-led innovation, resulting in a commercial playing field rich in collaboration. IP challenges are categorised by the complications of ownership in multi-party projects and the fast-changing case law around patenting in contentious areas such as medical methods, AI, data handling, software and commercialisation. HGF’s multidisciplinary teams are the ideal support in this evolving and complex sector.

 

Artificial limbs
Medical device

Our medical devices specialists

We’ve built our business by recruiting and developing specialists, not generalists. When it comes to protecting your ideas and business, you want to know you’re working with the best – people who truly understand your sector and the potential of your IP.

HGF’s team has medical devices professionals from an array of academic and business backgrounds. Our team-based approach ensures our clients benefit from the very best strategic advice from people who understand not only the legal environment but also the practical side of your business.

Let's talk

If you would like to discuss how HGF could help you, contact one of our medical devices specialists.

Latest news

HGF Ranked #1 in the UK for Trade Mark Portfolios in the 2025 Trade Mark Filing Trends Report by Clarivate.

HGF has achieved the #1 ranking for the UK for trade mark portfolios in the newly released 2025 Trade mark Filing Trends report by Clarivate, recognising the firm as a …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

A leading case - beware sequence errors in patent claims

Samsung Bioepis UK Ltd v Alexion Pharmaceuticals Inc [2025] EWHC 1240 (Pat) – Mr Justice Meade – 20 May 2025 The UK Patents Court has held that Samsung Bioepis’ and Amgen’s …

Read article

ICELAND left out in the cold by the General Court

Earlier in the month, the EU General Court issued its decision on Iceland Foods Ltd’s appeal of a decision of the Grand Board of Appeal of EUIPO to invalidate an …

Read article

HGF recognised in Managing IP’s New “Trusted Talent” Table in Germany

We are proud to announce that HGF has been ranked in Managing IP’s newly launched Trusted Talent table in Germany, a recognition of our ongoing commitment to excellence in intellectual …

Read article

Briefing Note: UKIPO SEP Consultation

Overview and Strategic Context The UKIPO’s 2025 consultation on Standard Essential Patents (SEPs), announced on 15 July 2025, signals a potential policy shift in how the UK approaches SEP licensing …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article